3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
10
Colorectal Neoplasms
5
Stomach Neoplasms
3
Rhabdomyosarcoma
3
Osteosarcoma
3
Biliary Tract Neoplasms
3
Small Cell Lung Carcinoma
2
Sarcoma, Ewing
2
Recurrence
2
Rectal Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Wilms Tumor
1
Small Bowel Adenocarcinoma
1
Sarcoma
1
Rhabdoid Tumor
1
Rectal Cancer Patients
1
Peritoneal Neoplasms
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Nasopharyngeal Carcinoma
1
Metastatic Gastric Adenocarcinoma
1
Metastatic Adenocarcinoma of the Pancreas
1
Malignant Ascites
1
Hepatoblastoma
1
Gastrointestinal Neoplasms
1
Gastroesophageal Junction Adenocarcinoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Interventions
Gemcitabine
5
Taxes
3
Albumin-Bound Paclitaxel
3
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Oxaliplatin
2
Losartan
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
130-nm albumin-bound paclitaxel
2
tocilizumab
1
selicrelumab
1
niraparib
1
durvalumab
1
dehydroftorafur
1
cobimetinib
1
atezolizumab
1
X-Rays
1
Tiragolumab
1
Standard of Care
1
Specimen Handling
1
Radiation
1
Panitumumab
1
Pancreaticoduodenectomy
1
PEGPH20
1
Optical Imaging
1
Nivolumab
1
Metformin
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Adenocarcinoma
×
irinotecan sucrosofate
×
1 year
×
Clear all
No trials found.